WINTON GROUP Ltd Invests $524,000 in Teleflex Incorporated $TFX

Posted by Brian Himes on Jun 11th, 2026

WINTON GROUP Ltd bought a new position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 4,296 shares of the medical technology company’s stock, valued at approximately $524,000.

Other hedge funds have also modified their holdings of the company. Banque Cantonale Vaudoise grew its position in shares of Teleflex by 82.5% during the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after acquiring an additional 113 shares during the last quarter. Hantz Financial Services Inc. grew its position in shares of Teleflex by 248.8% during the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock worth $34,000 after acquiring an additional 199 shares during the last quarter. V Square Quantitative Management LLC purchased a new position in shares of Teleflex during the fourth quarter worth approximately $37,000. Sound Income Strategies LLC purchased a new position in shares of Teleflex during the fourth quarter worth approximately $45,000. Finally, Danske Bank A S purchased a new position in shares of Teleflex during the third quarter worth approximately $54,000. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Price Performance

Shares of NYSE TFX opened at $132.27 on Thursday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The stock has a fifty day moving average price of $128.24 and a 200 day moving average price of $118.71. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $139.67. The company has a market cap of $5.86 billion, a PE ratio of -5.80, a P/E/G ratio of 1.01 and a beta of 0.82.

Teleflex (NYSE:TFX – Get Free Report) last released its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The company had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. During the same quarter last year, the company earned $1.44 earnings per share. Teleflex’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 6.7 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is -5.96%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and increased their price target for the stock from $135.00 to $155.00 in a report on Friday, May 8th. Truist Financial reaffirmed a “hold” rating and set a $143.00 price target (up from $135.00) on shares of Teleflex in a report on Monday, May 11th. Wall Street Zen downgraded Teleflex from a “hold” rating to a “sell” rating in a report on Saturday, May 9th. Needham & Company LLC increased their price target on Teleflex from $138.00 to $147.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. Finally, Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $140.00 to $160.00 in a report on Monday. Four research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $146.00.

View Our Latest Stock Analysis on TFX

Teleflex Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.